Beauty Image Efficacy Study

Pharmanex

Status

Completed

Conditions

Skin Aging

Treatments

Dietary Supplement: Placebo Control

Dietary Supplement: Beauty Image

Study type

Interventional

Funder types

Industry

Identifiers

NCT04733755

C180201

Details and patient eligibility

About

The objective is to evaluate the effects of oral supplement of a blend containing collagen peptides, phosphatidylserine, Saussurea involucrata and lutein (Beauty Image) on the improvement of skin aging in terms of hydration, gloss, melanin content, roughness and wrinkling, and anti-UV performance.

Enrollment

80 patients

Sex

All

Ages

28 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Facial skin with problems of dull, uneven, inelastic, dryness and wrinkle/fine line (At least fit to two problems)
In general good health and good mental state;
Willing to read, understand and able to sign the Informed Consent Form;
Willing to comply with all study protocol requirements.

Exclusion criteria

Intention to become pregnant, pregnant, lactating or within 6 months of delivery;
Participation in any clinical test or cosmetic product test on skin within 30 days;
Existence of neurodermatitis, pityriasis, seborrheic dermatitis or psoriasis capitis on test area;
Use of any anti-inflammatory drugs in the past 2 months;
A history of skin diseases such as psoriasis, eczema, psoriasis, skin cancer, etc.;
IDDM: Insulin dependent diabetic patients;
Current treatment for asthma or other chronic respiratory diseases;
Undergoing anticancer chemotherapy in the past 6 months;
Existence of any other health problems or chronic diseases;
Use of retinoids, alpha hydroxyl acid, ortho-hydroxybenzoic acid, hydroquinone nearly within 3 months; or use of prescriptions (such as antibiotics, retinoids, alpha hydroxyl acid or steroids), oral contraceptives (Use of same contraceptives for 6 months excepted);
Existence of the following conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results, including, but not limited to, diabetes, vascular disease, hepatitis, eczema, psoriasis.